NR4A1 and hepatocellular carcinoma: Our previous finding indicated that Nur77 could activate gluconeogenesis in HCC cells by interacting with and stabilizing PEPCK1 in the cytoplasm, thereby counteracting the glycolysis process and inhibiting HCC growth [21].